Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CHI-902 for Treatment of Social Anxiety Disorder - A Phase IIb Randomized Double-Blind Placebo-Controlled Clinical Trial

NCT04086342 is registered in ClinicalTrials.gov with Canopy Growth Corporation as lead sponsor.

NCT NCT04086342
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04086342 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CHI-902 for Treatment of Social Anxiety Disorder - A Phase IIb Randomized Double-Blind Placebo-Controlled Clinical Trial
Lead sponsor
Canopy Growth Corporation
Phase
Phase 2
Overall status
Withdrawn
Start date
January 24, 2020
Completion date
January 26, 2021
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder